Overview

Drug Use Investigation Of Azithromycin IV For Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan)

Status:
Completed

Trial end date:
2016-04-22

Target enrollment:

Participant gender:

Summary

To collect the efficacy and safety information of Azithromycin IV related to their appropriate use in daily practice

Details

Lead Sponsor:

Pfizer

Treatments:

Azithromycin